Oncotarget: Retaining nanomolar potency in lung cancer with therapy-refractory mutations
User Oncotarget on YouTube,
Oncotarget published "The acylfulvene alkylating agent, LP-184, retains nanomolar potency in non-small cell lung cancer…
Oncotarget published "The acylfulvene alkylating agent, LP-184, retains nanomolar potency in non-small cell lung cancer…
Oncotarget published this trending research paper on April 13, 2021, entitled, "The acylfulvene alkylating agent, LP-184…
View the latest oncology-focused research published in this week’s issue of Oncotarget, Volume 12, Issue 8. Click here for the…